LXRs can also reduce the proinflammatory effects of TNFα and iNOS through inhibiting Phosphoinositide 3-kinase and JNK signaling to attenuate LPS-mediated liver injury in mice with NAFLD (Liu et al., 2012). Here, TNF is linked to metabolic dysfunction-associated steatotic liver disease.